:

MONK RAISES $25M SERIES A FOR AR AUTOMATION

AI DESK1 MIN READ
WED, APR 22, 2026

■ AI-SUMMARIZED FROM 1 SOURCE BELOW

Monk, a platform automating accounts receivable workflows, secured $25 million in Series A funding co-led by Footwork and Acrew Capital. The round brings the company's total funding to $29 million.

Monk's Series A reflects growing investor interest in automation tools targeting back-office finance operations. The platform streamlines accounts receivable processes, reducing manual work and accelerating cash collection for businesses. Footwork and Acrew Capital jointly led the round, with CEO George Kurdin confirming the funding. The company's path to $29 million in total capital suggests prior seed or pre-Series A rounds. Accounts receivable automation remains an active area for venture funding as companies seek efficiency gains in finance operations. Monk competes in a broader category of tools addressing invoice processing, payment tracking, and collections workflows. The funding will likely support product development and sales expansion as Monk scales its customer base across mid-market and enterprise segments.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Esther and Anne Wojcicki have joined Mary Minno's new healthcare accelerator program Treehub and early-stage venture fund AI Health Fund, both focused on startups at the intersection of healthcare and artificial intelligence.

3H AGOIndustry Desk

Cursor paused its $2 billion funding round after SpaceX offered a $10 billion collaboration fee and a path to a $60 billion acquisition, fundamentally altering the AI coding startup's trajectory.

6H AGOAI Desk

Storage software company Vast Data has raised $1 billion in Series F funding, tripling its valuation to $30 billion. CEO Renen Hallak announced the company is preparing for an initial public offering.

6H AGOIndustry Desk

10x Science has secured $4.8 million in seed funding to help pharmaceutical researchers interpret the flood of AI-generated molecular candidates. The startup addresses a critical gap: AI can propose drugs faster than humans can evaluate them.

7H AGOAI Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.